XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

XIX International AIDS Conference. Session "Gender and Science: Shifting the Paradigm in HIV Research" discussing the inclusion of structural and biological gender factors as part of HIV research, and the participation of women living with HIV in clinical trials.

XIX International AIDS Conference. Interview with Bernhard Schwartzlander from UNAIDS in Geneva. Schwartzländer is an expert on the statistics of HIV/AIDS. He talks about the HIV prevalence globally and the importance of early diagnosis and ARV treatment.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Interview with Pathologist Christian Isichei, founder of the Faith Alive Hospital in Jos in Nigeria. He talks about the drug industry and access to ARV treatment in Africa and his experiences from the annual conference at the Institute of Human Virology (IHV) in Baltimore.

This film is about the global AIDS situation. The film starts in Europe and the United States and ends up in Zimbabwe and Uganda. It tells about the global disparities of drug access, but also about the successful HIV and AIDS responses of Thailand, Cambodia and Uganda.